The Ornithine Transcarbamylase (OTC) Deficiency Treatment market has demonstrated steady expansion, driven by advances in therapeutic approaches and increasing diagnosis rates worldwide. This niche yet critical industry segment reflects evolving market trends and dynamic growth trajectories shaped by innovation and unmet medical needs. Market Size and Overview The Global Ornithin... https://hallbook.com.br/blogs/817772/Ornithine-Transcarbamylase-OTC-Deficiency-Treatment-Market-Size-and-Emerging-Trends